NDC 60505-6236
Deferoxamine mesylate
Deferoxamine Mesylate
Deferoxamine mesylate is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Deferoxamine Mesylate.
| Product ID | 60505-6236_bd585bc2-1383-72b7-61c3-9e57591c05c2 |
| NDC | 60505-6236 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferoxamine mesylate |
| Generic Name | Deferoxamine Mesylate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2021-11-05 |
| Marketing Category | ANDA / |
| Application Number | ANDA207384 |
| Labeler Name | Apotex Corp. |
| Substance Name | DEFEROXAMINE MESYLATE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |